Crms Clinical Research Management Services Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-12-2024
- Paid Up Capital ₹ 0.10 M
as on 24-12-2024
- Company Age 10 Year, 24 Days
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2020)
- Ebitda
- Net Worth -14.29%
(FY 2020)
- Total Assets %
(FY 2020)
About Crms Clinical Research Management Services
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Devesh Kumar and Madhur Saxena serve as directors at the Company.
- CIN/LLPIN
U74120UP2014PTC067680
- Company No.
067680
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Dec 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Crms Clinical Research Management Services?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhur Saxena  | Director | 18-Dec-2014 | Current |
| Devesh Kumar | Director | 18-Dec-2014 | Current |
Financial Performance of Crms Clinical Research Management Services.
Crms Clinical Research Management Services Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Crms Clinical Research Management Services?
In 2018, Crms Clinical Research Management Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ir Innovate Research Private LimitedActive 10 years 2 monthsDevesh Kumar and Madhur Saxena are mutual person
- Cts Clinical Trial Services India Private LimitedActive 9 years 11 months
Devesh Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Crms Clinical Research Management Services?
Unlock and access historical data on people associated with Crms Clinical Research Management Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Crms Clinical Research Management Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crms Clinical Research Management Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
